On behalf of our member companies that provide more than 1 million jobs in the state and make the New Jersey Business & Industry Association the largest statewide business association in the country, NJBIA is opposed to A-583 (Moriarty, Danielsen) which would establish a Prescription Drug Review Commission to establish a “maximum price” for any […]
On behalf of our members representing over 1 million jobs in New Jersey, the New Jersey Business & Industry Association (NJBIA), respectfully OPPOSES S-3202 (Lagana, Gopal). This legislation requires hospitals to provide breast cancer patients with information concerning reconstructive surgery, prohibits certain provisions in managed care plan contracts. NJBIA is concerned that this measure would […]
The NJ Small Employer Health Benefits Program Board, housed within the New Jersey Department of Banking and Insurance, held a meeting on Wed., Nov. 14. Chrissy Buteas, Chief Government Affairs Officer, NJBIA, was appointed to the board to represent small employers. Additionally, the board received an annual update on the loss ratio and refund reports […]
Bulletin No. 18-14, Implementation of P.L. 2018, c. 32 (N.J.S.A. 26:2SS-1 to -20) Out-of-Network Consumer Protection, Transparency, Cost Containment and Accountability Act, has been issued by the New Jersey Department of Banking and Insurance (DOBI). On June 1, 2018, the Out-Of-Network Consumer Protection, Transparency, Cost Containment, and Accountability Act, P.L. 2018, c. 32 (codified at N.J.S.A. […]
The Health Affairs Policy Committee will host a meeting on Friday, Feb. 1, 2019 at NJBIA – 10 West Lafayette Street, Trenton. You can register for our meeting here. More information to follow in 2019.